NBIX William H Rastetter sells $3.3M worth of shares
May 08, 2025, 4:34 AM
0.00%
What does NBIX do
Neurocrine Biosciences, based in San Diego, develops pharmaceuticals for neurological disorders and employs 1,448 people. Its FDA-approved products include INGREZZA and Orilissa, with a strong clinical development pipeline.
William H Rastetter sold 30,000 shares of NBIX on 5 May at $110.20 per share, worth a total of $3.3M. They now own 37,491 NBIX shares, or a 44% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
